Subscribe to Search results

Kevin Guinness responded to Ian Snedden by letter stating that it was important to keep in regular touch over this issue to ensure "a consistent presentation of policy, which as you say is ultimately a matter for collective consideration by the Government."

Published on:

James Douglas-Hamilton wrote to Winifred Ewing MEP affirming both the lack of plans to make payments (on the ground of no negligence) and the "best treatment available" line.

Published on:

Memo from Ian Snedden to Kevin Guinness noted that if it were agreed that compensation should be made, the only practical option would be to make payment to all individuals, not just haemophiliacs, infected by blood, blood products or tissue.

Published on:

Gary Wildridge responded to Scottish Solicitors enquiring about the likelihood of an ex gratia payment scheme being established for patients infected with Hepatitis B or C as a result of NHS treatment. He stated the Government did not accept there had been negligence and there were no plans to make ex gratia payments.

Published on:

Andy Nichol advised Sam Galbraith that Mr Dobson, Secretary of State for Health, would be announcing that the Department of Health would not be offering compensation to individuals infected with Hepatitis C through NHS treatment, and recommended that a similar position be adopted in Scotland.

Published on:

Sam Galbraith, Minister in the Scottish Office, agreed to adopt a similar position in Scotland as in England, namely, not to offer compensation to those infected with Hepatitis C through NHS treatment.

Published on:

A memo from Michael Palmer to the Minister for Health and Community Care, Susan Deacon, explained the BBC was planning to run a story regarding claims for compensation from people with haemophilia who had contracted Hepatitis C. It was to be claimed that in Scotland the heat treatment required to kill the virus was not introduced until a year after it was applied in England, and that that was negligent.

Published on:

A memo from Michael Palmer to the Minister for Health and Community Care, Susan Deacon, stated that although there was a period between 1986 and 1987 when Scottish products were not as safe from Hepatitis C as English products, it was not due to negligence on part of the SNBTS and it was not feasible to import safer English product, because not enough of the product could be produced for domestic English consumption.

Published on:

A memo from Michael Palmer to the Minister for Health and Community Care, Susan Deacon, included a line to take in response to a BBC story regarding claims for compensation from people with haemophilia who had contracted Hepatitis C.

Published on:

A memo from Michael Palmer to the Minister for Health and Community Care, Susan Deacon, informed her of legal advice in England suggesting that the Department of Health would probably be liable for a failure to introduce for screen for Hepatitis C as quickly as it should have done. The advice suggested compensation should be paid to anyone anyone who contracted the virus between May 1991 and September 1991 when screening became universally available, and this was a considerable shift in policy.

Published on:

A memo from Michael Palmer to the Minister for Health and Community Care, Susan Deacon, repeated that "The Government's position has been that there is no fault on the part of the NHS because patients received the best treatment available given the state of knowledge at the time."

Published on:

In a press release from the Haemophilia Society, Philip Dolan, speaking on behalf of Scottish members, appealed to the Scottish Parliament "who could decide to act now for Scottish people with haemophilia and HCV."

Published on:

Margaret Smith MSP, convener of the Health and Community Care Committee, wrote to Susan Deacon calling for an immediate Executive Inquiry to allay public fear and concerns about the safety of Scottish blood products.

Published on:

Michael Palmer informed Susan Deacon, that officials had already written to SNBTS, Department of Health and haemophilia clinicians in Scotland requesting detailed information on events raised by Margaret Smith MSP on 6 August 1999, and provided a draft reply from the Minister to Margaret Smith MSP.

Published on:

Michael Palmer, Dr Keel, Lynda Towers and Sandra Falconer met Professor Ian Franklin of SNBTS and Drs Robert Perry and Ron McIntosh of PFC to discuss the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.

Published on:

Fax from Jane Kelly of PFC to Mike Palmer at the Department of Health, Scottish Office, including a document titled Factor VIII Concentrates manufactured by SNBTS (1974-1999).

Published on:

Background Notes on the Development of Hepatitis-Safe Factor 8 concentrates were produced by SNBTS.

Published on:

Michael Palmer wrote to the SNBTS National Director regarding the investigation of circumstances surrounding the safety of SNBTS blood products from Hepatitis C.

Published on:

Dr Robert Perry wrote to Michael Palmer providing Background Notes on the Development of Hepatitis-Safe Factor VIII Concentrate by SNBTS.

Published on:

Professor Lowe and Professor Ludlam confirmed that it was normal practice within their centres to inform patients of the result of a test if they were found to be HCV positive.

Published on: